R50
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Informed Consent: Participants (parents) are able to provide informed consent and understand the nature of the study as well as their involvement in it.
Exclusion criteria
Exclusion criteria: Lack of Consent: Children whose parents or legal guardians do not provide consent to participate in the study. No Access to Internet or Smartphone: Lack of access to the internet or a smartphone.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The frequency of antipyretic use per febrile episode, with an episode considered complete when the child has been fever-free for 48 consecutive hour | — |
Secondary
| Measure | Time frame |
|---|---|
| - Safety: How safe do you currently feel in dealing with your child's fever? (Likert 1-5): daily during a fever episode and at the beginning and end of the overall study - Well-being: How is your child ( Likert 1-5) daily during a fever episode - Episode duration in days | — |
Countries
Germany
Contacts
Barbara Apotheke Kamen